Edwards Lifesciences Corp (EW)

111.69
0.41 0.37
NYSE : Health Care
Prev Close 111.28
Open 111.65
Day Low/High 110.97 / 111.99
52 Wk Low/High 81.12 / 121.75
Volume 1.09M
Avg Volume 1.21M
Exchange NYSE
Shares Outstanding 211.16M
Market Cap 23.80B
EPS 2.70
P/E Ratio 34.15
Div & Yield N.A. (N.A)

Latest News

Edwards Lifesciences: Cramer's Top Takeaways

Edwards Lifesciences: Cramer's Top Takeaways

Mike Mussallem, chairman and CEO of Edwards Lifesciences, tells Jim Cramer about his company's heart-valve advancements.

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'

Edwards Lifesciences Achieves #82 Analyst Rank, Surpassing Western Digital

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #82 spot from Western Digital Corp , according to ETF Channel. Below is a chart of Edwards Lifesciences Corp versus Western Digital Corp plotting their respective rank within the S&P 500 over time (EW plotted in blue; WDC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Edwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020

Now accepting grant proposals to help address the global burden of heart valve disease

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.

Edwards Lifesciences Is Not Skipping A Beat

Edwards Lifesciences Is Not Skipping A Beat

Is this the report the bulls have been waiting for?

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord is bullish on Edwards Lifescience stock.

UK Patent Court Issues Initial Decision

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

These stocks are indicating a change in direction.

Analysts' Actions -- CVS, Edwards Lifesciences, Qorvo, Tesoro and More

Analysts' Actions -- CVS, Edwards Lifesciences, Qorvo, Tesoro and More

Here are Thursday's top research calls, including downgrades for CVS, Edwards Lifesciences and Qorvo, and an upgrade for Tesoro.

Edwards Lifesciences Is Recovering From a Bearish Gap

Edwards Lifesciences Is Recovering From a Bearish Gap

However, more consolidation may be needed before the uptrend resumes.

Boost in Small-Business Confidence Is a Big Deal: Cramer's 'Mad Money' Recap

Boost in Small-Business Confidence Is a Big Deal: Cramer's 'Mad Money' Recap

The small business survey signals more building, more hiring, and more buying, Jim Cramer says.

Edwards Lifesciences Shows Signs of Life

Edwards Lifesciences Shows Signs of Life

Still, volume and positive money flow will need to improve to sustain a breakout move in the name.

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.

Edwards' Life Goes On Without Big M&A

Edwards' Life Goes On Without Big M&A

As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

'Mad Money Lightning Round: Go Long on Pandora

'Mad Money Lightning Round: Go Long on Pandora

Cramer says he likes Twilio for the long term and is taking Nvidia over Himax.

TheStreet Quant Rating: B+ (Buy)